Researchers from the Sant Pau Research Institute (IR Sant Pau) have demonstrated, in a preclinical study, the effectiveness of a targeted nanotoxin in inhibiting colorectal cancer growth. The study, p...
Read moreA study led by Dr. Ariadna Tibau, researcher at the Sant Pau Research Institute (IR Sant Pau) and oncologist at Hospital de Sant Pau, was recently published in the journal JAMA Network Open. The artic...
Read moreIdentifican características clínicas y moleculares específicas del cáncer de mama asociado al embarazo (PABC) que abren la posibilidad de orientar futuras estrategias terapéuticas personalizadas ...
Read moreSegún datos de la Sociedad Española de Oncología Médica (SEOM), durante 2025 habrá 44.573 nuevos casos, concretamente 30.311 de colon y 14.262 de recto.
Read moreLa colaboración del Complejo Asistencial Universitario de Salamanca a través del IBSAL y del Hospital Virgen de Rocío, mediante el Instituto de Biomedicina de Sevilla, ha logrado la financiación d...
Read moreHospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regulatory authority (AEMPS).
Read moreCNIO researchers discover that, in mice that eat a lot of fat, cancer cells travelling through the blood surround themselves with platelets, which act as an armor-like protection as they spread.
Read moreLa AECC financia una investigación de la Clínica que coordina junto al Hospital Clínic de Barcelona y el Instituto de Investigación Hospital Gregorio Marañón centrado en la nutrición como compl...
Read moreThe Journal of Hepatology has published a study led by Josep M Llovet’s team at IDIBAPS-Hospital Clínic identifying the molecular characteristics associated with responses or resistance to treatmen...
Read moreLed by investigators of VHIO’s Radiomics Group, a review article published in ESMO Real-World Data and Digital Oncology—the European Society for Medical Oncology’s latest peer-reviewed open acce...
Read moreLa medicina personalizada o de precisión aprovecha los avances biotecnológicos en diversas disciplinas para mejorar el diagnóstico y adaptar las terapias a la singularidad de cada paciente.
Read moreUn grupo multidisciplinar de especialistas del Hospital Clínico San Carlos ha creado la primera unidad de inmunoprevención de cánceres hematológicos que existe en Europa en la que aplican un nuevo...
Read more